Belay Diagnostics

Belay Diagnostics develops three proprietary cerebrospinal fluid (CSF) liquid biopsy tests designed to help clinicians detect and manage primary and secondary central nervous system malignancies, including brain and spinal cord tumors. The tests provide genomic profiling as a minimally invasive alternative to traditional methods like cytology, MRI, and tissue biopsies for diagnosis, classification, and treatment planning.